Form D Explorer
ADIAL PHARMACEUTICALS, INC. · CIK 1513525

Report a data issueCitable research briefCompare issuerPrivate research collection

ADIAL PHARMACEUTICALS, INC.

CIK 1513525 · Corporation · Inc. DELAWARE · GLEN ALLEN, Virginia · Pharmaceuticals
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
May 14, 2025
through Dec 3, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 14, 2025 · DDec 3, 2025 · DLater minus earlier
Reported offering amount$4,815,379$4,285,289$-530,090
Reported amount sold$4,815,379$4,285,289$-530,090
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001213900-25-042848 · Later SEC source: 0001213900-25-117804

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Dec 3, 2025

Reported offering amount
$4,285,289
Reported exemptions
Rule 506(b)
Reported amount sold
$4,285,289

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (2)